Protalix BioTherapeutics Inc (PLX)
1.11
-0.14
(-11.20%)
USD |
NYAM |
May 10, 16:00
1.11
0.00 (0.00%)
After-Hours: 20:00
Protalix BioTherapeutics Total Return Level: 1.25 for May 9, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 09, 2024 | 1.25 |
May 08, 2024 | 1.14 |
May 07, 2024 | 1.14 |
May 06, 2024 | 1.11 |
May 03, 2024 | 1.14 |
May 02, 2024 | 1.16 |
May 01, 2024 | 1.21 |
April 30, 2024 | 1.14 |
April 29, 2024 | 1.20 |
April 26, 2024 | 1.15 |
April 25, 2024 | 1.18 |
April 24, 2024 | 1.21 |
April 23, 2024 | 1.20 |
April 22, 2024 | 1.18 |
April 19, 2024 | 1.15 |
April 18, 2024 | 1.13 |
April 17, 2024 | 1.15 |
April 16, 2024 | 1.14 |
April 15, 2024 | 1.14 |
April 12, 2024 | 1.18 |
April 11, 2024 | 1.22 |
April 10, 2024 | 1.26 |
April 09, 2024 | 1.32 |
April 08, 2024 | 1.30 |
April 05, 2024 | 1.17 |
Date | Value |
---|---|
April 04, 2024 | 1.21 |
April 03, 2024 | 1.24 |
April 02, 2024 | 1.24 |
April 01, 2024 | 1.25 |
March 28, 2024 | 1.26 |
March 27, 2024 | 1.25 |
March 26, 2024 | 1.22 |
March 25, 2024 | 1.22 |
March 22, 2024 | 1.27 |
March 21, 2024 | 1.32 |
March 20, 2024 | 1.34 |
March 19, 2024 | 1.30 |
March 18, 2024 | 1.27 |
March 15, 2024 | 1.33 |
March 14, 2024 | 1.37 |
March 13, 2024 | 1.52 |
March 12, 2024 | 1.43 |
March 11, 2024 | 1.44 |
March 08, 2024 | 1.49 |
March 07, 2024 | 1.46 |
March 06, 2024 | 1.48 |
March 05, 2024 | 1.52 |
March 04, 2024 | 1.57 |
March 01, 2024 | 1.62 |
February 29, 2024 | 1.63 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
0.81
Minimum
Jan 27 2022
6.45
Maximum
Feb 09 2021
2.305
Average
1.915
Median
Total Return Level Benchmarks
Agenus Inc | 11.71 |
InfuSystems Holdings Inc | 7.56 |
AIM ImmunoTech Inc | 0.4366 |
Perspective Therapeutics Inc | 1.80 |
Armata Pharmaceuticals Inc | 3.26 |